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The mechanism of linear growth reduction during GnRHa
treatment in central precocious puberty has not been
elucidated.
Aim
To investigate the pattern of serum amino-terminal
proC-type natriuretic peptide (NT proCNP) in healthy
girls throughout puberty, and the changes of serum NT
proCNP in girls with idiopathic central precocious pub-
erty (ICPP) before and during gonadotropin-releasing
hormone analog(GnRHa) therapy.
Methods
Serum levels of E2, NT proCNP, insulin like growth factor
1(IGF1), NMID Osteocalcin(OC) and carboxy-terminal
cross-linking telopeptide of type I collagen (b-CrossLaps)
were measured in healthy 57 girls at different pubertal
stages, and in 13 girls with ICPP at the beginning and the
end of 6th month and 12th month of GnRHa treatment.
Height velocities of the 13 ICPP girls in each 6 months
before and after GnRHa treatment was calculated.
Results
Serum NT proCNP level increases as the progress of pub-
ertal development and peaks at the late puberty (P<0.01),
paralleling with serum E2 and IGF1 levels, like with the
pattern of height velocity. All of serum NT proCNP,
Osteocalcin and b-CrossLaps level decrease significantly in
ICPP girls at the end of 6th months of GnRHa therapy
(P<0.01 or P<0.05), and remain the same low level at the
end of 12th month of GnRHa. Different from the aboved
markers, serum IGF1 level remains high before and during
GnRHa treatment despite growth deceleration.
Conclusions
Linear growth reduction in girls with ICPP treated with
GnRHa is due at least in part to decreased CNP mediated
long bone growth after estrogen inhibition. Serum NT
proCNP can be used as a biological marker of long bone
growth indicating the activity of epiphyseal growth plate.
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